Tilbake til søkeresultatene

PES2020-Prosj.etabl.støtte H2020

Calanus Oil - aiming for clinical studies

Tildelt: kr 79 999

The Company offers unique Arctic Marine Bioactives – including its “third generation omega 3” Calanus® Oil, providing functional properties and health benefits to humans. Calanus® Oil is a new ingredient with a different chemistry compared to other omega-3 products on the market; it is composed of wax esters with surprising efficacies and with potential novel areas of use. Preclinical data involving Calanus® Oil have demonstrated a strong anti-obesogenic efficacy, which is seen only at much higher eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) doses when delivered in the chemical form of purified ethyl esters (EE) or triacylglycerols (TAG) from fish oil. The aim of CALANUS WORKSHOP 2018 is to develop an international strong R&D group which can enable Calanus AS to gain mechanistic insight to understand the biomedical potency, as well as the market potential, of Calanus® Oil. This workshop initiated by the company will bring scientists, clinicians, regulatory competence and business developers together with the objective of critically evaluate the available information and suggest the best routes forward in terms of R&D and documentation. Having this knowledgebase in place, the company will actively seek for relevant calls withing Horizon 2020, or adher as an SME to already existing consortium invitations.

Budsjettformål:

PES2020-Prosj.etabl.støtte H2020